AZURE Study
A Phase 3 study investigating whether an investigational medication can reduce the risk of heart attack or stroke in adults with cardiovascular disease or at high risk. Compensation up to $1,600.
ROCHE Weight Loss Study
A Phase 3 study evaluating an investigational medication for chronic weight management in adults with obesity or overweight without Type 2 Diabetes. Compensation up to $3,500.